New England Research & Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $514K | Sell |
|
|||||
|
2025
Q2 | $1.11M | Hold |
|
|||||
|
2025
Q1 | $1.17M | Buy |
|
|||||
|
2024
Q4 | $403K | Hold |
|
|||||
|
2024
Q3 | $479K | Hold |
|
|||||
|
2024
Q2 | $480K | Sell |
|
|||||
|
2024
Q1 | $430K | Hold |
|
|||||
|
2023
Q4 | $428K | Sell |
|
|||||
|
2023
Q3 | $450K | Hold |
|
|||||
|
2023
Q2 | $476K | Hold |
|
|||||
|
2023
Q1 | $462K | Sell |
|
|||||
|
2022
Q4 | $464K | Hold |
|
|||||
|
2022
Q3 | $376K | Hold |
|
|||||
|
2022
Q2 | $453K | Sell |
|
|||||
|
2022
Q1 | $766K | Sell |
|
|||||
|
2021
Q4 | $922K | Sell |
|
|||||
|
2021
Q3 | $1.2M | Buy |
|
|||||
|
2021
Q2 | $967K | Sell |
|
|||||
|
2021
Q1 | $1.06M | Sell |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|
|||||
|
2020
Q3 | $315K | Sell |
|
|||||
|
2020
Q2 | $312K | Hold |
|
|||||
|
2020
Q1 | $264K | Hold |
|
|||||
|
2019
Q4 | $295K | Hold |
|
|||||
|
2019
Q3 | $263K | Hold |
|
|||||
|
2019
Q2 | $244K | Hold |
|
|||||
|
2019
Q1 | $239K | Hold |
|
|||||
|
2018
Q4 | $224K | Sell |
|
|||||
|
2018
Q3 | $238K | Hold |
|
|||||
|
2018
Q2 | $211K | Hold |
|
|||||
|
2018
Q1 | $210K | Sell |
|
|||||
|
2017
Q4 | $257K | Sell |
|
|||||
|
2017
Q3 | $569K | Buy |
|
|||||
|
2017
Q2 | $244K | Sell |
|
|||||
|
2017
Q1 | $531K | Sell |
|
|||||
|
2016
Q4 | $521K | Buy |
|
|||||
|
2016
Q3 | $205K | Sell |
|
|||||
|
2016
Q2 | $777K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $210K | Hold |
|
|||||
|
2015
Q1 | $226K | Hold |
|
|||||
|
2014
Q4 | $232K | Buy |
|
|||||
|
2014
Q3 | $218K | Hold |
|
|||||
|
2014
Q2 | $227K | Buy |
|